Fundz

Vera Dermics, Inc reported raising $22.2 Million in an amended SEC Form D filing, from an offering of $22.2 Million

PUBLIC · MANEOct 07, 2021

Amount Raised

$22.2 Million

$22.2 Million sold, per SEC Form D (first sale Oct 7, 2021)

Round Type

Venture

West HartfordHealthcareHealth Care

Quick answer

VeraDermics raised $22.2 Million in a funding round, dated October 7, 2021. VeraDermics is based in West Hartford, Connecticut, United States.

How much did VeraDermics raise?
VeraDermics raised $22.2 Million in a funding round on October 7, 2021.
What does VeraDermics do?
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Where is VeraDermics based and how big is it?
VeraDermics is based in West Hartford, Connecticut, United States.
Who are the decision-makers at VeraDermics?
Fundz holds 1 contact at VeraDermics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as VeraDermics that raised within 45 days of this round, from Fundz verified event records.

  • Geneoscopy raised $51M on November 19, 2021.
  • ViaLase raised $27M on November 19, 2021.
  • TuHURA Biosciences raised $5.1M on November 19, 2021.
  • CathAid raised $350K (Seed) on November 18, 2021.
  • Novabay raised $15M on November 17, 2021.
  • Cala Health raised $77M (Funding Round) on November 16, 2021.

Who to call at VeraDermics, and when

A new round usually means VeraDermics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VeraDermics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VeraDermics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VeraDermics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VeraDermics

Location

West Hartford, Connecticut, United States

About

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care. We are on a mission to make long-ignored dermatology and aesthetics conditions simple, replacing false hope, confusion, and questionable results with solutions that people and providers can trust. Our lead investigational product has the potential to be the first non-hormonal oral therapeutic for hair regrowth in women and men. Pattern hair loss, also known as androgenetic alopecia, is the largest aesthetics condition worldwide, with no new approved prescription therapies in nearly 30 years.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VeraDermics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsReid W., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VeraDermics's next move

See what Strategic adds

VeraDermics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.